News

Two plant-based compounds — ferulic acid and wogonin — may help protect the liver in cholestasis by influencing the growth of certain gut bacteria,…

About one year of treatment with Altimmune’s experimental therapy pemvidutide led to reductions in noninvasive markers of liver scarring (fibrosis) in people with metabolic…

Throughout 2025, the team at Liver Disease News has reported on the latest research and advances in care related to various rare and non-rare liver…

Women who develop severe intrahepatic cholestasis of pregnancy (ICP) at a later time in pregnancy have a higher risk of stillbirth, a study shows.

Health Canada has conditionally approved Novo Nordisk’s Wegovy (semaglutide) to treat metabolic dysfunction-associated steatohepatitis (MASH), a severe form of fatty liver disease. The…

Livmarli (maralixibat) and Bylvay (odevixibat) not only offer significant relief from severe itching in children with Alagille syndrome, but also improve quality…

Researchers in the U.S. have developed a rapid point-of-care test that detects active hepatitis C infection by identifying HCV RNA, with results available in…

Galangin, a naturally occurring compound found in honey and certain plants, was shown to reduce inflammation and liver injury in a mouse model of…

About half of children with progressive familial intrahepatic cholestasis (PFIC) were found to have cirrhotic cardiomyopathy (CCM), a form of heart disease, in a…

The U.S. Food and Drug Administration (FDA) has authorized the use of the first artificial intelligence (AI) drug-development tool for use in clinical trials of metabolic…